<SEC-DOCUMENT>0001558370-18-006443-index.html : 20180806
<SEC-HEADER>0001558370-18-006443.hdr.sgml : 20180806
<ACCEPTANCE-DATETIME>20180806160151
ACCESSION NUMBER:		0001558370-18-006443
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20180731
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180806
DATE AS OF CHANGE:		20180806

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gemphire Therapeutics Inc.
		CENTRAL INDEX KEY:			0001638287
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				472389984
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37809
		FILM NUMBER:		18994711

	BUSINESS ADDRESS:	
		STREET 1:		17199 N. LAUREL PARK DRIVE
		STREET 2:		SUITE 401
		CITY:			LIVONIA
		STATE:			MI
		ZIP:			48152
		BUSINESS PHONE:		248-980-6538

	MAIL ADDRESS:	
		STREET 1:		17199 N. LAUREL PARK DRIVE
		STREET 2:		SUITE 401
		CITY:			LIVONIA
		STATE:			MI
		ZIP:			48152
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>gemp-20180731x8k.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: gemp-20180731x8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>gemp-20180731ex416ef151f.htm
<DESCRIPTION>EX-4.1
<TEXT>
Document 2 - file: gemp-20180731ex416ef151f.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>gemp-20180731ex101f436e2.htm
<DESCRIPTION>EX-10.1
<TEXT>
Document 3 - file: gemp-20180731ex101f436e2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>gemp-20180731ex991c2464b.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 4 - file: gemp-20180731ex991c2464b.htm

</DOCUMENT>
</SEC-DOCUMENT>